RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles

Displaying items 12-22
  • FDA's lax approach to foreign drug safety endangers Americans

    BALTIMORE Talk about closing the barn door years after the rustlers have made off with your horses! U.S. Food and Drug Administration Commissioner Margaret Hamburg returned last month from her first official trip to India seeking to persuade the Indian...
  • Exploring therapeutic effects of MDMA on post-traumatic stress

    Exploring therapeutic effects of MDMA on post-traumatic stress
    It costs about $2,000 to buy an ounce of the illegal drug, the therapist said — enough for roughly 150 doses. She pays her longtime dealer in cash; he gives her a Ziploc bag of white powder. Back home, she scoops the contents into clear capsules....
  • Toyota may pay $1 billion to settle federal criminal investigation

    Here's how Toyota Motor Corp. plans to finally put the sudden-acceleration issue to rest: Pull out the checkbook. The automaker is reportedly close to paying a $1-billion fine to settle a four-year federal criminal investigation into whether it properly...
  • Solarize Enfield Contract Deadline Is April 15

    Residents interested in Solarize Enfield have until April 15 to sign contracts under the Solarize program. Solarize Enfield offers discounted rates on solar systems through a state-town sponsored program, and the average Solarize customer can expect...
  • Back Story: Book examines last peacetime year before outbreak of World War I

    Back Story: Book examines last peacetime year before outbreak of World War I
    In his recently published "1913: The Year Before The Storm," German journalist Florian Illies compiles a fascinating and exhaustively researched month-by-month compendium of the events, personalities, culture, politics, technology and fashions that shaped...
  • Herbalife takes another bite out of Bill Ackman

    Followers of Herbalife, the Los Angeles peddler of nutritional supplements, know it's actually two stories rolled into one. One is the story of how a company with a questionable business model, overhyped products, and an almost invisible research and...
  • Seniors should guard against shingles

    Seniors should guard against shingles
    Pneumonia, flu and shingles all affect seniors disproportionately to the rest of the population. These vaccine-preventable diseases account for more than 50,000 deaths annually in the U.S., according to the Alliance for Aging Research in its newly...
  • FDA says new cholesterol drugs may not need outcome studies

    FDA says new cholesterol drugs may not need outcome studies
    Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
  • Planned layoffs jumped in October on drug, financial firm cutbacks

    WASHINGTON -- Planned layoffs by U.S. employers jumped 13.5% last month, led by cutbacks at pharmaceutical and financial services firms, according to a report Wednesday. Employers announced plans to cut 45,730 jobs in October, up from 40,289 the...
  • Drug maker Merck laying off 8,500 in strategy overhaul

    Drug maker Merck laying off 8,500 in strategy overhaul
    Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.  That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
  • FDA bars medications made by Indian generics giant Ranbaxy

    FDA bars medications made by Indian generics giant Ranbaxy
    The Food & Drug Administration on Monday barred the import of any medications made at the premier manufacturing plant of one of the world's largest makers of generic medications, Ranbaxy Laboratories Ltd. The FDA cited Ranbaxy's failure to respond...